Position history for FARALLON CAPITAL MANAGEMENT LLC's holdings in BRIDGEBIO PHARMA INC
FARALLON CAPITAL MANAGEMENT LLC holds 9.4M shares of BBIO (BRIDGEBIO PHARMA INC), worth $695.5M as of 2026-Q1. The position was increased (+4.1% shares). BBIO represents 4.0% of FARALLON CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$695.5M
Current Shares
9.4M
Total Value Change
+$651M
Total Shares Change
+7.6M
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 9.4M |
+4.1% |
| $695.5M |
| 4.0% |
| $64.53 |
60 |
| 2025-Q4 | Increased | 9M | +9.8% | $688.3M | 3.2% | $75.48 | 64 |
| 2025-Q3 | Increased | 8.2M | +3.7% | $425.5M | 1.7% | $51.96 | 51 |
| 2025-Q2 | Increased | 7.9M | +37.9% | $341.1M | 1.5% | $44.86 | 64 |
| 2025-Q1 | Increased | 5.7M | +36.6% | $198.1M | 1.1% | $35.11 | 63 |
| 2024-Q4 | Increased | 4.2M | +140.1% | $115.1M | 0.6% | $27.32 | 68 |
| 2024-Q3 | New | 1.7M | - | $44.5M | 0.2% | $24.94 | 48 |